2024 PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT Group Lymphoma Working Party (LWP) 1st listed author Juan Montoro Journal Blood Adv.
2024 Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group Group Infectious Diseases Working Party (IDWP) 1st listed author Anne Mea Spanjaart Journal Leukemia.
2024 Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies Group WP/Committee not specified 1st listed author Christian Chabannon Journal Best Practice & Research Clinical Haematology
2024 Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author José Luis Piñana Journal Curr Res Transl Med.
2024 Outcome of Hematopoietic Stem Cell Transplantation in 813 Pediatric Patients with Fanconi Anemia Group Severe Aplastic Anaemia Working Party (SAAWP) Paediatric Diseases Working Party (PDWP) 1st listed author Su Han Lum Journal Blood.
2024 Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Bone Marrow Transplant.
2024 Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT Group WP/Committee not specified Other society 1st listed author Anna Sureda Journal Bone Marrow Transplant.
2024 Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years Group Lymphoma Working Party (LWP) 1st listed author Philipp Berning Journal Blood Cancer J.
2024 Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) Group Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Fermin Sanchez-Guijo Journal Cytotherapy.
2024 Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group Group Autoimmune Diseases Working Party (ADWP) Patient Advocacy Committee Nursing Research Committee Nursing Scientific Committee 1st listed author Tobias Alexander Journal J Allergy Clin Immunol Glob.
2024 Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Gesine Bug Journal Bone Marrow Transplant.
2024 How risky is a second allogeneic stem cell transplantation? Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.